Literature DB >> 6881780

Sample size nomograms for interpreting negative clinical studies.

M J Young, E A Bresnitz, B L Strom.   

Abstract

In recent years there has been increasing attention to the appropriate interpretation of a clinical study. One special concern has been the difficulty inherent in interpreting studies that were not statistically significant: Was the sample size sufficient to detect a clinically important effect if, in fact, it existed? This concern is further complicated because readers may have differing opinions of what size effect is clinically important. A pair of sample size nomograms has been developed, using common levels of statistical significance, to assist in this interpretation. The nomograms are intended to provide the clinician with a handy and easy-to-use reference for ascertaining whether an apparently negative study has a sample size adequate to detect reliably any difference between treatment groups that the clinician believes is clinically important. Examples are provided to show these principles and the use of the nomograms in interpreting negative studies.

Mesh:

Year:  1983        PMID: 6881780     DOI: 10.7326/0003-4819-99-2-248

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  25 in total

Review 1.  Determination of the clinical importance of study results.

Authors:  Malcolm Man-Son-Hing; Andreas Laupacis; Keith O'Rourke; Frank J Molnar; Jeffery Mahon; Karen B Y Chan; George Wells
Journal:  J Gen Intern Med       Date:  2002-06       Impact factor: 5.128

Review 2.  The implications for Europe of revised FDA guidelines for clinical trials with anti-infective agents.

Authors:  D N Gilbert; T R Beam; C M Kunin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-07       Impact factor: 3.267

3.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.

Authors:  J S Solomkin; E P Dellinger; N V Christou; R W Busuttil
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

4.  [The use of lipid containing nasal ointment for allergic rhinitis--a therapeutic option? A bicentric, prospective, open, randomised, controlled clinical study].

Authors:  U W Geisthoff; M Rupp-Classen; A Blum; P K Plinkert
Journal:  HNO       Date:  2005-12       Impact factor: 1.284

5.  Comparison of Pharmaceutical Calculations Learning Outcomes Achieved Within a Traditional Lecture or Flipped Classroom Andragogy.

Authors:  H Glenn Anderson; Lisa Frazier; Stephanie L Anderson; Robert Stanton; Chris Gillette; Kim Broedel-Zaugg; Kevin Yingling
Journal:  Am J Pharm Educ       Date:  2017-05       Impact factor: 2.047

6.  Evaluation of the Glasgow Coma Scale score in critically ill infectious disease patients.

Authors:  B Barsić; E Marton; J Himbele; Z Ravlić
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

7.  Three different mask physiotherapy regimens for prevention of post-operative pulmonary complications after heart and pulmonary surgery.

Authors:  U M Ingwersen; K R Larsen; M T Bertelsen; K Kiil-Nielsen; M Laub; J Sandermann; K Bach; H Hansen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.

Authors:  A Islam; T Butler; I Kabir; N H Alam
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Efficacy of a single dose of furazolidone for treatment of cholera in children.

Authors:  G H Rabbani; T Butler; M Shahrier; R Mazumdar; M R Islam
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee.

Authors:  M Bianchi; M Broggini
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.